Trial Profile
A phase III trial of Vitreosolve in patients with diabetic retinopathy.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Sep 2011
Price :
$35
*
At a glance
- Drugs Vitreosolve (Primary)
- Indications Diabetic retinopathy
- Focus Registrational; Therapeutic Use
- 10 Mar 2011 New trial record